BriaCell Therapeutics Corp.
Suite 300 – 235 15th Street
West Vancouver, BC V7T 2X1
February 18, 2021
Securities and Exchange Commission
Division of Corporation Finance
100 F Street N.E.
Washington, D.C. 20549
| Attention: | Ms. Abby Adams and Mr. Joseph McCann |
| Re: | BriaCell Therapeutics Corp. | |||
| Registration Statement on Form F-1 | File No. 333-234292 |
Ladies and Gentlemen:
Pursuant to Rule 461 promulgated under the Securities Act of 1933, as amended, BriaCell Therapeutics Corp. (the “Company”) hereby respectfully requests acceleration of the effectiveness of the above-referenced Registration Statement so that such Registration Statement will become effective as of 5:00 p.m. Eastern Time, February 23, 2021, or as soon as practicable thereafter.
| Very truly yours, | ||
| BriaCell Therapeutics Corp. | ||
| By: | /s/ William V. Williams | |
| William V. Williams | ||
| Chief Executive Officer | ||